Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Death, Esophageal Neoplasms, Glioblastoma, Lung Diseases, Lung Neoplasms, Melanoma, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Stomach Neoplasms, Thoracic Neoplasms, Urogenital Neoplasms, Disease Progression, Small Cell Lung Carcinoma

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT04436120 2024-12-03

TRANSLATE

Phase NA Terminated

38 enrolled 17 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Disease Progression

NCT03973671 2024-03-28

ProCaB

Recruiting

300 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT06235853 2024-02-01

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Completed

240 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT06170177 2023-12-14

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Recruiting

4,000 enrolled

Genitourinary

Urinary Bladder Neoplasms, Disease Progression

NCT05704231 2023-01-30

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Phase NA Unknown

60 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence, Smoking, Disease Progression

NCT04033432 2022-04-27

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Unknown

14 enrolled 13 charts

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT04617743 2022-04-12

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

Unknown

500 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT05146635 2022-01-11

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Phase NA Unknown

110 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT04723121 2021-01-25

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

Phase NA Completed

204 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT04213664 2020-01-02

LMR

Unknown

4,666 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Disease Progression

NCT03715660 2019-11-21

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

Phase NA Completed

198 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT04167332 2019-11-18

ProCSUCaB

Not yet recruiting

630 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT02538432 2019-11-04

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Phase 2 Withdrawn

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Disease Progression

NCT03174912 2017-06-05

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Phase 4 Completed

400 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03138824 2017-05-23

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Phase NA Unknown

100 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT03121768 2017-05-16

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Unknown

761 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Recurrence, Disease Progression

NCT01886677 2017-03-03

Improving Energy Balance in Men With Prostate Cancer

Phase NA Completed

40 enrolled

Genitourinary

Motor Activity, Prostatic Neoplasms, Weight Loss, Disease Progression

NCT02443844 2015-05-14

Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression

Phase 4 Unknown

40 enrolled

Genitourinary

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT01692262 2014-06-19

PYRUS

Phase 1 Completed

59 enrolled

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT00172367 2008-09-26

Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma

Phase 2 Withdrawn

80 enrolled

Genitourinary

Carcinoma, Transitional Cell, Uremia, Disease Progression

Clinical Trials

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

REMRI

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

TRANSLATE

ProCaB

Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Can We Predict of the Response of High Risk Non Muscle Invasive Bladder Cancer Patients to Intravesical Bacillus Calmette-Guerin? The Role of Immunological Markers

LMR

Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study

ProCSUCaB

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both?

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Improving Energy Balance in Men With Prostate Cancer

Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression

PYRUS

Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma